Expand VERA Menu
VERA MENU

VERA Latest Press Releases

-- July 10, 2026 --

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- July 9, 2026 --

Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner Globe Newswire 8:00 AM

-- July 7, 2026 --

Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA for Adult Patients with Primary IgA Nephropathy Globe Newswire 12:37 PM

-- June 5, 2026 --

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- June 2, 2026 --

Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy Globe Newswire 7:00 AM

-- May 8, 2026 --

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- May 7, 2026 --

Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results Globe Newswire 7:30 AM

-- May 4, 2026 --

Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference Globe Newswire 7:30 AM

-- April 10, 2026 --

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- March 27, 2026 --

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- March 25, 2026 --

Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer Globe Newswire 7:30 AM

-- March 6, 2026 --

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- March 5, 2026 --

Vera Therapeutics Appoints Christopher Hite to Board of Directors Globe Newswire 9:00 AM
Market Data Delayed 15 Minutes